Why Is Mar-Cof CG So Hard to Find? [Explained for 2026]

You've had a persistent cough, your doctor wrote you a prescription for Mar-Cof CG, and now your pharmacy doesn't have it in stock. You're not alone. Many patients across the U.S. run into difficulty filling prescriptions for codeine-containing cough syrups — and there are real, specific reasons why.

In this guide, we'll explain exactly why Mar-Cof CG can be difficult to find, whether there's an active shortage, and what steps you can take today to get your prescription filled.

What Is Mar-Cof CG?

Mar-Cof CG is a combination prescription cough syrup that contains two active ingredients: codeine phosphate (7.5 mg per teaspoon) and guaifenesin (225 mg per teaspoon). It is manufactured by Marnel Pharmaceuticals, LLC and distributed by Allegis Pharmaceuticals, LLC.

Codeine is an opioid antitussive — it works by suppressing the cough reflex in the brain. Guaifenesin is an expectorant that thins and loosens mucus in the airways, making it easier to cough up. Together, they provide both cough suppression and mucus relief. The syrup is alcohol-free and sugar-free, making it suitable for patients who need to avoid those ingredients.

Because it contains codeine, Mar-Cof CG requires a prescription in every state and is classified as a DEA Schedule V controlled substance. This classification is one of the primary reasons it can be harder to find than standard cough medicines.

Why Is Mar-Cof CG Hard to Find at Pharmacies?

Mar-Cof CG availability comes down to several intersecting factors. Unlike a simple OTC cough medicine, this drug operates under the full regulatory framework for controlled substances — which shapes how pharmacies stock and dispense it.

Here are the most common reasons patients struggle to fill their Mar-Cof CG prescription:

• Controlled substance stocking decisions. Pharmacies are not required to stock every Schedule V product. Many smaller or independent pharmacies may choose not to carry codeine-containing cough syrups because of the added DEA compliance burdens, storage requirements, and paperwork involved.
• Low demand relative to alternatives. With OTC alternatives like dextromethorphan (Delsym) and guaifenesin (Mucinex) widely available, and prescription alternatives like benzonatate being very popular, demand for codeine cough syrups like Mar-Cof CG is lower than it was a decade ago. Lower demand means pharmacies order less, and some stop carrying it altogether.
• Limited distribution channel. Mar-Cof CG is a specific brand made by a smaller pharmaceutical manufacturer. It doesn't have the widespread distribution network of a large national brand, which can lead to regional availability gaps.
• Dispensing restrictions. Because codeine is a controlled substance, pharmacies must follow strict dispensing rules including verifying prescriptions and tracking dispensing in state prescription drug monitoring programs (PDMPs). This adds friction that discourages some pharmacies from stocking it.
• State-by-state variation. While Mar-Cof CG is federally classified as Schedule V, some states apply their own, stricter scheduling. In those states, the prescription and dispensing requirements may be more burdensome, reducing the number of pharmacies willing to carry it.

Is There an Active FDA Shortage of Mar-Cof CG in 2026?

As of 2026, Mar-Cof CG does not appear on the FDA's official drug shortage database as an active shortage. This is an important distinction: being hard to find is not the same as being on the FDA shortage list.

The FDA shortage list primarily tracks drugs where there is a widespread manufacturing or supply-chain disruption affecting the national supply. Mar-Cof CG's availability issues are more a function of controlled substance pharmacy stocking practices than a manufacturing crisis.

That said, patients in rural areas or smaller towns may find it particularly challenging since there are simply fewer pharmacies to call. In larger metro areas, chain pharmacies (CVS, Walgreens, Walmart, Kroger) are more likely to have it in stock.

How the Schedule V Label Affects Where You Can Get Mar-Cof CG

The DEA Schedule V classification for codeine-containing cough syrups is the lowest (least restrictive) schedule, but it still carries meaningful implications for pharmacies and patients alike.

For pharmacies, stocking a Schedule V controlled substance means maintaining separate DEA records, tracking each dispensing, and being subject to DEA audits. For a product with low turnover, many pharmacies decide the compliance cost isn't worth it.

For patients, this means you may need to call several pharmacies before finding one that carries it. And even at pharmacies that do stock it, they may have limited quantities — running out between orders.

What Should You Do If You Can't Find Mar-Cof CG?

If your first pharmacy is out of stock, don't give up. Here are your most practical options:

1. Use medfinder. medfinder calls pharmacies near you to check which ones have Mar-Cof CG in stock. Instead of spending 30–45 minutes calling pharmacies yourself, medfinder does that work and texts you results.
2. Try larger chain pharmacies. CVS, Walgreens, Walmart, and Kroger pharmacies typically have higher controlled substance inventory than independent pharmacies. Start with these.
3. Ask your doctor about alternatives. Several effective alternatives exist, including benzonatate and dextromethorphan-based products. See our guide on Mar-Cof CG alternatives for a full comparison.
4. Ask the pharmacy to order it. If a pharmacy stocks it but is temporarily out, ask them to place a special order. Most pharmacies can order and receive controlled substances within 1–3 business days.
5. Check with a compounding pharmacy. Some compounding pharmacies can prepare a codeine/guaifenesin formulation if your prescriber writes for a compounded preparation. This requires a new prescription from your doctor.

Why Do Doctors Still Prescribe Mar-Cof CG When Alternatives Exist?

You might wonder — if finding Mar-Cof CG is a hassle, why don't doctors just prescribe something easier to fill? The truth is, for some patients, codeine-based cough syrups work when other options don't. Patients who have tried dextromethorphan or benzonatate without adequate relief may respond better to codeine's stronger opioid mechanism.

Additionally, the guaifenesin component in Mar-Cof CG provides expectorant activity that many pure cough suppressants lack. For patients with a productive wet cough who also need cough suppression, this dual-action formula offers a distinct benefit.

The Bottom Line on Mar-Cof CG Availability in 2026

Mar-Cof CG is not in an FDA-declared shortage, but its Schedule V controlled substance status, limited distribution, and lower stocking priority at many pharmacies mean you may have to call around to find it. The good news: it is available — you just may need to check more than one pharmacy.

medfinder was built exactly for situations like this. We call local pharmacies on your behalf to find which ones have Mar-Cof CG in stock, then text you the results. Visit medfinder.com to get started — and spend your energy recovering, not calling pharmacies.